1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
121.40 -3.57 (-2.86%)
220.2K
XNAS Volume

XNAS 03 Mar, 2026 12:34 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Repligen Corp is on 13 Mar 2026 for the purpose of Repligen Corp Annual Report for 2025 See details

Repligen Corp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents